SuperworthNeuronetics market cap STIM
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $160.8M
- Highest close in our data
- $442M
- Jun 2021
Neuronetics is worth $160.8M at the close on Oct 23, 2026, at $2.11 a share.
That is down 22% over the last year and up 17% over five years.
Its highest close in our data was $442M in Jun 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $160.8M | $83.5M | $251.5M | +65% |
| 2025 | $97.3M | $45.2M | $301.4M | +117% |
| 2024 | $44.9M | $21.5M | $141.6M | −46% |
| 2023 | $83.9M | $30.3M | $179.9M | −55% |
| 2022 | $187M | $63.5M | $187M | +59% |
| 2021 | $117.6M | $104.2M | $442M | −44% |
| 2020 | $210.8M | $26.3M | $210.8M | +151% |
| 2019 | $83.8M | $78.6M | $337.4M | −75% |
| 2018 | $333.8M | $313.1M | $435.1M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Neuronetics' size, closest first, today.
| Company | Market cap |
|---|---|
| STIMNeuronetics | $160.8M |
| PDEXPro DEX | $199.3M |
| UTMDUtah Medical Products | $236.3M |
| KEQUKewaunee Scientific | $94.9M |
| INFUInfuSystem | $277.6M |
| EMBCEmbecta | $380.2M |
| APTAlpha Pro Tech | $56.7M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| NEPHNephros | $38.3M |
| MOVMovado | $701.9M |
| Peer median | $257M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Neuronetics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.